Anti-CD40L antibody frexalimab slows new brain lesions in multiple sclerosis
Thiago de Amorim Carvalho
Topics & Concepts
Multiple sclerosisMedicineTranslational researchDiseaseTranslational medicineAntibodyClinical researchImmunologyClinical efficacyAutoimmune diseaseIntensive care medicineInternal medicinePathologyMonoclonal and Polyclonal Antibodies Research